Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.37 USD | -0.85% |
|
-4.10% | -15.75% |
07-15 | JPMorgan Trims Price Target on Alkermes to $31 From $32, Maintains Neutral Rating | MT |
07-01 | Alkermes plc(NasdaqGS:ALKS) dropped from Russell 2000 Dynamic Index | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.75% | 3.99B | |
+22.15% | 46.55B | |
+45.94% | 41.84B | |
-2.37% | 40.84B | |
+33.84% | 32.95B | |
-6.35% | 28.27B | |
+20.42% | 27.78B | |
+48.83% | 14.26B | |
+45.00% | 13.69B | |
+0.06% | 12.18B |
- Stock Market
- Equities
- ALKS Stock
- News Alkermes plc
- Transcript : Alkermes plc Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-11-2023 11